Skip to main content

$0.078 -0.005 (-6.02%)

High

$0.08

Low

$0.08

Trades

3

Turnover

$11,867

Volume

152,018
30 June 2023 at 3:20pm
Register to track BGT and receive email alerts.
Subject
BGT Ann: Participation at Credit Suisse Asia Investor Conference

BGT Ann: Cleansing Statement

BGT Ann: Application for quotation of securities - BGT

BGT Ann: Proposed issue of securities - BGT

BGT Ann: Strategic Placement of $1.5 million to Cornerstone Investor

BGT Ann: Positive Stored Grain Pest Results

BGT Ann: Grant of United States Patent

BGT Ann: Cleansing Statement

BGT Ann: Change of Director's Interest Notice - P May

BGT Ann: Change of Director's Interest Notice - A Guthrie

BGT Ann: Change of Director's Interest Notice - J Joughin

BGT Ann: Change of Director's Interest Notice - P Beetham

BGT Ann: Change of Director's Interest Notice - R Jagger

BGT Ann: Change of Director's Interest Notice - R Klupacs

BGT Ann: Application for quotation of securities - BGT

BGT Ann: Appendix 4D - Half Year Accounts - 31 December 2021

BGT Ann: Bio-Gene Receives R&D Tax Incentive

BGT Ann: Bio-Gene Announces Appointment of Head of Regulatory Affairs

BGT Ann: Appendix 4C - 31 December 2021

BGT Ann: Results of Meeting - EGM

BGT Ann: Notification of cessation of securities - BGT

BGT Ann: EGM 270122 - Shareholder Letter, Notice of Meeting and Proxy

BGT Ann: Cleansing Statement

BGT Ann: Application for quotation of securities - BGT

BGT Ann: Proposed issue of securities - BGT

BGT Ann: Bio-Gene Completes Capital Raising of $3.2 Million

BGT Ann: Trading Halt

BGT Ann: Bio-Gene to Progress Synergy Research

BGT Ann: Appendix 3G

BGT Ann: Bio-Gene Virtual Presentation at V-Con

BGT Ann: Results of Meeting

BGT Ann: Bio-Gene 2021 AGM - CEO's Presentation

BGT Ann: Bio-Gene 2021 AGM - Chairman's Address

BGT Ann: Bio-Gene 2021 AGM Presentation

BGT Ann: 2021 Notice of Annual General Meeting/Proxy Form

BGT Ann: Bio-Gene Investor Briefing

BGT Ann: Appendix 4C - 30 September 2021

BGT Ann: Bio-Gene Technology Investor Briefing

BGT Ann: Bio-Gene Executes Option Agreement with Clarke

BGT Ann: Bio-Gene Commercial Agreement with Evergreen Garden Care

BGT Ann: Successful Allowance of New United States Patent

BGT Ann: Notice Under ASX Listing Rule 3.13.1

BGT Ann: Bio-Gene to Present at Australian Mosquito Control Symposium

BGT Ann: Appendix 4G and 2021 Corporate Governance Statement

BGT Ann: Appendix 4E and 2021 Annual Report

BGT Ann: Share Buy-Back Notices

BGT Ann: Update - Notification of buy-back - BGT

BGT Ann: Update - Notification of buy-back - BGT

BGT Ann: Clarification of Share Buy-back Notices

BGT Ann: Notification of buy-back - BGT

Register to track BGT and receive email alerts.

Similar Companies

DNK
KLL
NUF
PWN
RWD
SO4
TGH